Antiviral agent.
Specifically suppresses influenza A and B viruses associated with severe acute respiratory syndrome. By the mechanism of antiviral action refers to fusion inhibitors (fusion), interacts with hemagglutinin of the virus and prevents fusion of the lipid shell of the virus and cell membranes. It has a moderate immunomodulatory effect.
It has interferon-inducing activity, stimulates humoral and cellular immune reactions, phagocytic function of macrophages, increases resistance of the body to viral infections. It reduces the frequency of complications associated with viral infections, as well as exacerbations of chronic bacterial diseases.
Therapeutic effectiveness in viral infections is shown in reduction of general intoxication and clinical manifestations, shortening of the duration of illness, reduction of the risk of complications.
It is classified as low-toxic compound (LD50 >4 g/kg). It does not have any negative effect on human body when administered orally in recommended doses.
Indications
Prevention and treatment in adults and children: influenza A and B, acute respiratory infections, severe acute respiratory syndrome (including those complicated by bronchitis, pneumonia); secondary immunodeficiency states; complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection.
Prevention of postoperative infectious complications and normalization of the immune status.
The complex therapy of acute intestinal infections of rotavirus aetiology in children over 3 years old.
Active ingredient
Composition
Capsulated white to white with a cream color, round, biconvex, rough, white to white with a greenish-yellowish or creamy color on the break.
1 tablet umiphenovir hydrochloride 100 mg
Excipients:
Lactose monohydrate – 0.1722 g,
povidone K25 (polyvinyl-pyrrolidone medium molecular) – 0.0064 g,
crospovidone – 0.0094 g,
colloidal silicon dioxide (aerosil) – 0.009 g,
magnesium stearate – 0.003 g.
Composition of the film coating:
Opadray II white [lactose monohydrate – 36%, hypromellose – 28%, titanium dioxide – 26%, macrogol-4000 (polyethylene glycol 4000) – 10%] -0.012 г.
Directions for use
Ingestion, before meals.
Daily dose (depending on age):
Age
Price dose of the drug
from 3 to 6 years old
50 mg (1 50 mg tablet)
6 to 12 years
100 mg (2 tablets of 50 mg or 1 tablet of 100 mg)
older than 12 years and adults
200 mg (4 50 mg tablets or 2 100 mg tablets)
The indication
The drug regimen
In a single dose once a day for 10-14 days.
The treatment of influenza and other acute respiratory infections
a day (every 6 hours) for 5 days.
Comprehensive therapy of chronic bronchitis, pneumonia and recurrent herpes infection
In a single dose 4 times a day (every 6 hours) for 5-7 days, then a single dose 2 times a week for 4 weeks.
Prevention of postoperative infectious complications
in a single dose 2 days before surgery, then on the 2nd and 5th day after surgery.
Special Instructions
Contraindications
Side effects
Similarities
Weight | 0.015 kg |
---|---|
Shelf life | 2 years. Do not use after the expiration date printed on the package. |
Conditions of storage | At a temperature not higher than 25 ° C. Keep out of reach of children. |
Manufacturer | Tatkhimpharmpreparaty, Russia |
Medication form | pills |
Brand | Tatkhimpharmpreparaty |
Related products
Buy Afludol, 100 mg 20 pcs. with delivery to USA, UK, Europe and over 120 other countries.